Please login to the form below
19
Revenue 2017Celgene
The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Celgene's 2013 oncology sales performance.
HTA guidance from NICE, the SMC and the AWMSG
Celgene has scored a positive recommendation from England’s cost-effectiveness watchdog NICE for Revlimid in follicular lymphoma, chalking up another indication.
J&J aims for US approval of MS drug ponesimod
many hurdles to the completion of its acquisition of Celgene, which developed the drug.
BMS, AbbVie’s Empliciti flunks trial in first-line multiple myeloma
The 750-patrient ELOQUENT-1 trial showed that adding Empliciti (elotuzumab) to background treatment with BMS/Celgene’s Revlimid (lenalidomide) and dexamethasone didn’t extend the time patients with newly-diagnosed ... BMS will draw some comfort from
FDA approves Sanofi’s key cancer drug Sarclisa for myeloma
Sarclisa will now be available for patients with relapsed or refractor multiple myeloma who have received at least two prior therapies, including Celgene’s Revlimid (lenalidomide) and a proteasome inhibitor.
Celgene’s Revlimid scores NICE approval in follicular lymphoma
According to Celgene, this approval opens the treatment up to over 600 patients in England, who were previously limited to clinical trials or palliative care. ... The approval came only a short time after Bristol-Myers Squibb completed its $74bn
Data provided by GlobalData
GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.
To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology
COVID-19 Updates and Daily News
Featured jobs
-
Account Manager (PR)
-
Great Benefits
-
Account Director, Medical Education
-
Salary TBC
-
Senior External Communications Lead
-
£Competitive Salary
-
Account Manager
-
£Competitive Salary
-
Senior Account Manager
-
Salary TBC
-
Account Director
-
£Competitive Salary
- Brand Manager - Medium Global Pharma Company
-
£Competitive Financial Package
- Account Director, Medical Communications & Events
-
£50 - 65, 000 according to skills and experience benefits
-
Senior Medical Writer
-
Salary TBC
-
Account Director – UK Office
-
Excellent salary and benefits
- Senior Medical Writer, MedComms Agency
-
Salary TBC
- Group Director of Medical Affairs and Scientific Strategy, Medic...
-
Substantial six figure package
- Senior Medical Writer or Lead Medical Writer
-
£Competitive Salary
- Account Manager, Healthcare Communications
-
£32, 000 - £40, 000 bonus benefits
- China backs use of Roche’s Actemra for coronavirus
- Germany's coronavirus infections climb but deaths remain low
- FDA approves Roche’s Actemra COVID-19 trial
- UK biotech Synairgen to begin COVID-19 trial of lead candidate
- COVID-19: Novel coronavirus remains stable on surfaces for hours
- Did Trump offer CureVac $1bn for COVID-19 vaccine rights?
- COVID-19 delays Pfizer, Mylan’s generics merger and spin-out
- UK contributes £210m towards COVID-19 vaccine efforts
- Bluebird bio pushes back commercial launch of Zynteglo due to COVID-19
- In virtual meeting, CHMP backs Sanofi’s myeloma drug Sarclisa
- COVID-19 message to clients from OPEN Health CEO, David Rowley
- The march to sustainability
PMHub
Weber Shandwick
At Weber Shandwick, engagement has always been the cornerstone of health communications.We make health matter. Health is a basic human...
Latest intelligence
- The role of women in science and technology
- Why the lack of female leaders in pharma and life sciences is a problem that still needs to be fixed...
- China’s homecoming heroes fuel a biotech boom with rapid CAR-T advances
- China secures a place at the forefront of innovative medicine...
- Virtual Research Grants Submission and Approval Program
- Impetus Digital summarizes how a client established an independent grant review committee and a virtual grant submission and approval program, without having to travel and meet in person....
Quick links
Infographics
